Clinicopathologic and expression of TMSG-1 and Cyclin D1 in esophageal squamous cell carcinoma
10.3969/j.issn.1006-5725.2016.17.014
- VernacularTitle:TMSG-1和Cyclin D1在食管鳞癌的表达及临床病理意义
- Author:
Bo LIU
;
Yang LV
;
Kun LI
;
Junchao LIU
;
Xiujuan LI
;
Wei SUN
- Publication Type:Journal Article
- Keywords:
Esophageal squamous cell carcinoma;
TMSG-1;
Cyclin D1;
Immunohistochemistry;
Prognosis
- From:
The Journal of Practical Medicine
2016;32(17):2829-2833
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study TMSG-1 and Cyclin D1 expressions in esophageal squamous cell carcinoma (ESCC) and their relevance to the clinicopathological data and prognosis. Methods Immunohistochemistry S-P method was used to examine the expressions of TMSG-1 and Cyclin D1 in pathological specimens of 136 cases of ESCC and 13 cases of normal esophageal mucosa. Contrast study among immunohistochemistry, clinicopathological data and prognosis was also analyzed. Results (1)The positive expression rates of TMSG-1 and Cyclin D1 in ESCC were 52.2% and 65.4%, respectively. The expressions of TMSG-1 and Cyclin D1 in ESCC were significantly higher than that in normal esophageal mucosa (P<0.05). (2)The expressions of TMSG-1 and Cyclin D1 were all related to clinical stage , differentiation degree and lymph node metastasis (P < 0.05). (3)The expression of TMSG-1 was negatively correlated to the expression of Cyclin D1 in ESCC (r=-0.386,P=0.000). (4)The expression levels of TMSG-1 and Cyclin D1 were independent risk factors in patients with ESCC (P < 0.05). Conclusions The abnormal expressions of TMSG-1 and Cyclin D1 may cooperatively play a role in initiation and development of ESCC. Co-examination of TMSG-1 and Cyclin D1 expressions in primary tumors may be useful for predicting prognosis of ESCC.
